FDA to weigh easing limits on unproven peptides Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022 Journal of Pharmaceutical Innovation Springer Nature Link The FDA just put peptides like BPC 157, TB 500, and KPV on the clock. , As a compounding pharmacist, this is literally my world and most people dont understand the regulatory nuance behind what FDA Peptide Update: Category 2 Removals Explained FDA mulls compounding for peptides previously flagged over safety risks BioSpace